Presentations from Representatives of the Sponsoring Agencies
|
|
|||||||||||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 207
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects
B
Open Session and Workshop Agendas
Open Session
Monday, September 23, 2002
National Academy of Sciences
Room 105
2100 C Street, NW
Washington, DC
1:00 p.m.
Welcome, Introductions, and Purpose of the Public Session
Bettie Sue Masters, Committee Chair
Presentations from Representatives of the Sponsoring Agencies
1:10
U.S. Department of Agriculture
Michael Schechtman, Office of the Deputy Secretary
Charles Edwards, Food Safety and Inspection Service
2:10
Food and Drug Administration
Joseph Levitt, Center for Food Safety and Applied Nutrition
James Maryanski, Center for Food Safety and Applied Nutrition
3:10
Break
3:30
U.S. Environmental Protection Agency
J. Thomas McClintock, Office of Science Coordination and Policy
OCR for page 208
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects
4:30
Open Discussion
4:45
Adjourn
Workshop
Tuesday, January 7, 2003
Keck Building
Room 100
500 Fifth Street, NW
Washington, DC
8:30 a.m.
Welcome and Introductory Remarks
Bettie Sue Masters, Committee Chair
8:45
Methods for Genetically Modifying Animals and Their Applications
José Cibelli, Advanced Cell Technology, Inc.
9:30
Toxicity? Transgene Expression in Muscle as a Food Product
Robert Schwartz, Baylor College of Medicine
10:15
Break
10:30
Determining Unintended Health Effects of Biotechnology-Derived Foods
Ian Munro, CanTox, Inc.
11:15
Assessing Foods Derived from Genetically Modified Crops for Unintended Effects—an Industry Perspective
Roy Fuchs, Monsanto Company
12:00 noon
Lunch
1:00 p.m.
Compositional Analyses of Foods and Feeds Derived from Biotechnology: A Lens into Unintended Effects
Bruce Chassy, University of Illinois, Urbana-Champaign
1:45
The Use of Profiling Methods for Identification and Assessment of Unintended Effects in Genetically Modified Foods
Harry Kuiper, RIKILT Wageningen University and Research Center, The Netherlands
2:30
Break
OCR for page 209
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects
2:45
The International Life Sciences Institute Crop Composition Database
Ray Shillito, Bayer CropScience
3:30
FDA Policy for Reviewing Genetically Engineered Crops: A Case-Study Assessment of FDA Oversight
Douglas Gurian-Sherman, Center for Science in the Public Interest
3:55
Public Comment Session
4:20
Closing Remarks
Bettie Sue Masters, Committee Chair
4:30
Adjourn
OCR for page 210
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects
This page intentionally left blank.
Representative terms from entire chapter:
unintended effects